Westfield Capital Management Co. LP grew its stake in shares of Vertex Pharmaceuticals by 133.8% in the third quarter.
BMO Capital Markets assumed coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report released on Wednesday morning, Ratings reports. The brokerage issued an outperform ...
16d
Fintel on MSNBMO Capital Initiates Coverage of Rocket Pharmaceuticals (RCKT) with Outperform RecommendationFintel reports that on March 12, 2025, BMO Capital initiated coverage of Rocket Pharmaceuticals (NasdaqGM:RCKT) with a ...
Chris has responsibility for all aspects of the JLABS @ San Francisco Bay Area, as well as supporting the broader ecosystem through external presence and partnerships. He leads sourcing and ...
West Pharmaceutical Services Inc. closed 43.99% below its 52-week high of $396.75, which the company achieved on April 8th.
NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West ...
Shares of West Pharmaceutical Services Inc. WST slid 2.63% to $225.80 Tuesday, on what proved to be an all-around favorable ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The analysts have sharply ...
Cash Equivalents and Short-term Investments: $238 million as of December 31, 2024, compared to $170 million as of December 30, 2023. Revenue: $26.6 million in Q4 2024 and $31.1 million for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results